Vapogenix Lands $5,100,000 Series B Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fccf6f76-53dc-4738-8463-9ad3aea6b951
Date
3/10/2015
Company Name
Vapogenix
Mailing Address
8285 El Rio St. Houston, TX 77054 USA
Company Description
Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain. While most pain is localized, most pain medications are administered orally (systemically), resulting in side effects.
Website
http://www.vapogenix.com
Transaction Type
Venture Equity
Transaction Amount
$5,100,000
Transaction Round
Series B
Proceeds Purposes
The company intends to use the funds to advance the aforementioned programs.
M&A Terms
Venture Investor
Venture Investor